Proton Pump Inhibitor Use, Hip Fracture and Change in Bone Density In Postmenopausal Women Results from the Women’s Health Initiative

BACKGROUND: Proton pump inhibitor (PPI) medications have been inconsistently shown to be associated with osteoporotic fractures. The objective was to examine the association of PPI use with bone outcomes (fracture, bone mineral density [BMD]) METHODS: This prospective analysis included 161,806 postm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arch Intern Med
Hauptverfasser: Gray, Shelly L., LaCroix, Andrea Z., Larson, Joseph, Robbins, John, Cauley, Jane A., Manson, JoAnn E., Chen, Zhao
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2010
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4240017/
https://ncbi.nlm.nih.gov/pubmed/20458083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archinternmed.2010.94
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge